EBITDA spoločnosti NeuroVive Pharmaceutical AB
Aká je hodnota metriky EBITDA spoločnosti NeuroVive Pharmaceutical AB?
Hodnota metriky EBITDA spoločnosti NeuroVive Pharmaceutical AB je -kr62.84
Aká je definícia metriky EBITDA?
EBITDA je zisk pred odpočítaním úrokov, daní, odpisov, a amortizácie reprezentujúci operačnú výkonnosť spoločnosti.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA spoločností v sektore Health Care sektor na OTC v porovnaní so spoločnosťou NeuroVive Pharmaceutical AB
Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy s metrikou ebitda podobnou spoločnosti NeuroVive Pharmaceutical AB
- Hodnota metriky EBITDA spoločnosti Fulgent Genetics Inc je -$63.48
- Hodnota metriky EBITDA spoločnosti Spectrum Pharmaceuticals je -$63.28
- Hodnota metriky EBITDA spoločnosti SQZ Biotechnologies Co je -$63.19
- Hodnota metriky EBITDA spoločnosti Hi-Level Technology je -HKD$62.98
- Hodnota metriky EBITDA spoločnosti Mansion International je -HKD$62.98
- Hodnota metriky EBITDA spoločnosti Sanghvi Forging & Engineering je -₨62.95
- Hodnota metriky EBITDA spoločnosti NeuroVive Pharmaceutical AB je -kr62.84
- Hodnota metriky EBITDA spoločnosti New Found Gold je -CAD$62.83
- Hodnota metriky EBITDA spoločnosti Lithium Americas je -$62.68
- Hodnota metriky EBITDA spoločnosti Grand Field je -HKD$62.66
- Hodnota metriky EBITDA spoločnosti Vincera Pharma je -$62.63
- Hodnota metriky EBITDA spoločnosti PLBY je -$62.63
- Hodnota metriky EBITDA spoločnosti Hind Aluminium Industries je -₨62.52